Soyon Hong and Tim Bartels are researchers at the UK Dementia Research Institute at UCL working together to transform what we know about Parkinson’s disease.
From Parkinson’s to Alzheimer’s, neurodegenerative diseases are on the rise — yet few therapies exist to combat them. That’s why the Collaborative Pairs program at CZI’s Neurodegeneration Challenge Network (NDCN) is bringing together scientists to explore new ideas and new approaches.
Meet science power couple Soyon Hong and Tim Bartels: two researchers at the UK Dementia Research Institute at UCL who have found hope in the midst of personal tragedy by combining their scientific expertise in a new project supported by the NDCN.
Learn more about how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
Losing my dad to Alzheimer’s disease was heartbreaking. But I have hope for the future, hope that society will one day be able to detect and treat brain diseases early.
I am a scientist. So is my husband. We’re working together on a new approach to neurodegeneration.
Our research starts with a question we’ve discussed for a long time at the dinner table: Does brain health begin in the gut?
The brain and the gut are connected by nerve cells (called the enteric nervous system). This gut-brain axis is a hot topic in research because it could be a conduit for disease.
Tim studies a protein known to build up in the gut during Parkinson’s disease before any signs of illness appear. Known as alpha-synuclein, this protein later forms clumps in the brain during the disease. I look at how nerve cells are protected by immune cells called tissue-resident macrophages. Are these cells failing during disease? Could this cause protein to build up and spread?
The two of us have worked on lots of projects together over the years — from that half-marathon we ran early in our relationship to our two kids.
But this is the first scientific collaboration between our two labs. You might say it’s the perfect marriage of our expertise!
Enjoy this story? Read about another pair of scientists who have teamed up to study, treat and prevent rare pediatric diseases.
The Chan Zuckerberg Initiative interviews Brian Wallach of I AM ALS, who is leading the fight to cure the rare neurodegenerative disease ALS.
The CZ Imaging Institute hosted a machine learning competition to streamline cryoET data analysis, and achieved milestones in the field along the way
Explore stories of people who have recovered from COVID-19 and how they are helping researchers better understand how this virus will impact our communities...
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.